Pharma & Biotech
You will receive alerts when there are new announcements on Motif Bio PLC
Only registered members can use this feature.
Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.
Motif is confident there is a path to market for iclaprim, it will require a company with deeper pockets to take the putative treatment further.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.